Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin

Shock

Volumn 10, Issue 1, 1998, Pages 13-19

  Wray, Gillian M ^a   Hinds, Charles J ^a   Thiemermann, Christoph ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 DIHYDROXYISOQUINOLINE; 1,5-DIHYDROXYISOQUINOLINE; 3 AMINOBENZAMIDE; 3-AMINOBENZAMIDE; BENZAMIDE DERIVATIVE; ENZYME INHIBITOR; ISOQUINOLINE DERIVATIVE; LACTIC ACID; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRATE; NITRITE; SUCCIMER;

ANIMAL; ARTICLE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; ENDOTOXEMIA; HEMODYNAMICS; HYPOTENSION; KIDNEY; LIVER; MALE; MULTIPLE ORGAN FAILURE; PANCREAS; PATHOPHYSIOLOGY; RAT;

ANIMALS; BENZAMIDES; ENDOTOXEMIA; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; HYPOTENSION; ISOQUINOLINES; KIDNEY; LACTIC ACID; LIVER; MALE; MULTIPLE ORGAN FAILURE; NIACINAMIDE; NITRATES; NITRITES; PANCREAS; POLY(ADP-RIBOSE) POLYMERASES; RATS; SUCCIMER;

EID: 0032113022     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199807000-00003     Document Type: Article

References (46)

1. Ikai K, Ueda K: Immunohistochemical demonstration of poly(adenosine diphosphate-ribose) synthetase in bovine tissues. J Histochem Cytochem, 31:1261-1264, 1983.
2. Ueda K, Hayaishi O: ADP-ribosylation. Ann Rev Biochem 54:73-100, 1985.
3. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG: Hydrogen peroxide induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 82:4908-4912, 1996.
4. Hyslop PA, Hinshaw DB, Halsey WA, Schraufstatter IU, Sauerheber RD, Spraggs RG, Jackson RG, Jackson JH, Cochrane CG: Mechanism of oxidant mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem 263:1665-1675, 1988.
5. Thies RL, Autor AP: Reactive oxygen injury to cultured pulmonary artery endothelial cells: Mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. Arch Biochem Biophys 286:353-363, 1991.
6. Zhang J, Dawson VL, Dawson TM, Snyder SH: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263:687-689, 1994.
7. Heller B, Wang ZQ, Wagner EF, et al: Inacitivation of the poly (ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 270:11176-80, 1995.
8. Szabo C, Zingarelli B, O'Connor M, Salzman AL: DNA strand breakage, activation of poly-ADP ribosyl synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 93:1753-1758,1996.
9. Aalto TK, Raivo KO: Nucleotide depletion due to reactive oxygen metabolites in endothelial cells: Effects of antioxidants and 3-aminobenzamide. Pediatr Res 34:572-576, 1993
10. Szabo C, Zingarelli B, Salzman AL: Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 78: 1051-1063, 1997.
11. Zingarelli B, Salzman AL, Szabo C: Protective effects of nicotinamide against nitric oxide mediated delayed vascular failure in endotoxic shock: Potential involvement of polyADP ribosyl synthetase. Shock 5:258-264, 1996.
12. Chabot F, Mitchell JA, Quinlan GI, Evans T: Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: Role of poly (adenosine 5′-diphosphoribose) synthase. Br J Pharmacol 121:485-490, 1997.
13. Banasik M, Komura H, Shimoyama M, Ueda K: Specific inhibitors of poly(ADP-ribose) synthetase and mono (ADP-ribosyl) transferase. J Biol Chem 267:1569-1575, 1992.
14. Baue AE: The multiple organ or system failure syndrome. In: Pathophysiology of Shock, Sepsis and Organ Failure. Schlag G, Redl H (eds), pp.1004-1018. Berlin: Springer Verlag, 1993.
15. Hewett JA, Roth RA: Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharide. Pharmacol Rev 45:3782-3411, 1993.
16. Thiemermann C, Ruetten H, Wu CC, Vane JR: The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845-2851, 1995.
17. Ruetten H, Southan GJ, Abate A, Thiemermann C: Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 188:261-270, 1996.
18. Schmidt HHHW, Warner TD, Nakane M, Forstermann U, Murad F: Regulation and subcellular location of nitric oxide synthases in RAW264.7 macrophages. J Exp Parmacol Ther 41:615-624, 1992.
19. Green LC, Ruiz de Luzuriaga K, Wagner DA. nitrate biosynthesis in man: Proc Natl Acad Sci USA 78:7764-7768, 1981
20. Thiemermann C: Use of selective inhibitors of inducible nitric oxide synthase in septic shock. Sepsis 1997; in press.
21. MacMicking JD, Nathan C, Hom G: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 82:641-650, 1995.
22. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR: Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114:1666-1672, 1995.
23. Ruetten, Thiemermann C: Prevention of the expression of inducible nitric oxide synthase by aminoguanidine or aminoethyl-isothiourea in macrophages and in the rat. Biochem Biophys Res. Commun. 225:525-530.
24. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 87:1620-1624, 1990.
25. Ischiroploulos H, Zhu L, Beckman J: Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 2:446-453, 1992
26. Althaus FR, Lawrence SD, Sattler GI, Pitot HC: ADP-ribosyltransferase activity in cultured hepatocytes: Interaction with DNA repair. J Biol Chem 257:5528-5535, 1982.
27. + depletion and cytotoxicity in isolated hepatocytes. Biochem Pharmacol 37:3967-3974, 1988.
28. Bowes J, Thiemermann C. Br J Pharmacol 1998; in press.
29. Thiemermann C, Bowes J, Myint FP, Vane JR: Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 94:679-683, 1997.
30. Zingarelli B, Cuzzocrea S, Zsengeller Z, Salzman A, Szabo C: Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 36:205-215, 1997.
31. Cuzzocrea S, Zingarelli B, Costantino G, et al: Beneficial effects of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacology 121:1065-1074, 1997.
32. Ledoux SP, Hall CR, Forbes PM, Patton NJ, Wilson GL: Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity. Diabetes 37:1015-1019, 1988.
33. Szabo C, Southan G, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methyl-isothiourea sulfate, a novel, potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
34. Ruetten H, Thiemermann C: Prevention by calpain inhibitor 1, an inhibitor of the proteolysis of IκB, of the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Br J Pharmacol 121:695-704, 1997.
35. Ruetten H, Thiemermann C: Effects of tyrphostins and genistein on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase? Br J Pharmacol 122:59-70, 1997.
36. Millar CGM, Thiemermann C: Intrarenal hemodynamics and renal dysfunction in endotoxemia: Effects of nitric oxide synthase inhibition. Br J Pharmacol 121:1824-1830, 1997.
37. Zhu L, Gunn C, Beckmann JS: Bactericidal activity of peroxynitrite. Arch Biochem Biophys 298:452-457, 1992.
38. Mizumoto K, Glasgott PA, Farber JL: Roles for oxidative stress and poly (ADP-ribosyl)ation in the killing of cultured hepatocytes by methyl methane sulfonate. Biochem Pharmacol 46:1811-1818, 1993.
39. Yamamoto Y, Tsukidate K, Farber JL: Differing effects of the inhibition of poly(ADP-ribose) polymerase on the course of oxidative cell injury in hepatocytes and fibroblasts. Biochem Pharmacol 46:483-491, 1993.
40. + depletion. Biochem Biophys Res Com 199:1270-1277, 1994.
41. Kallman B, Burkart VB, Kronke KD, Kolb-Bachofen V, Kolb H: Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci 51:671-678, 1992.
42. Hauschildt S, Schiepers P, Bessler WG, Mulsch A: Induction of nitric oxide synthase in L929 cells by tumour necrosis factor alpha is prevented by inhibitors of poly (ADP-ribose) polymerase. Biochem J 288:255-260, 1992.
43. Pellat-Deceunynck K, Wiezerbin J, Drapier JC: Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages. Biochem J 297:53-58, 1994.
44. Knowles RG, Merrett M, Salter M, Moncada S: Differential induction of brain, lung, and liver nitric oxide synthase by endotoxin in the rat. Biochem Biophys Res Commun 172:042-1048, 1990.
45. Szabo C, Mitchell JA, Thiemermann C, Vane JR: Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 108:786-792, 1993.
46. Eliasson MJL, Sampei K, Mandir AS et al: Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Medicine 10:1089-1095, 1997.